Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

96.69 +1.49 (+1.57%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

71 72 Next >

BioNTech, Oracle And 3 Stocks To Watch Heading Into Monday ↗

March 10, 2025

Via Benzinga

Nasdaq Falls Into Correction As Tariffs Roil Wall Street: What's Moving Markets Friday? ↗

March 07, 2025

All three major indices were red in Friday’s midday trading, with the S&P 500 and Nasdaq 100 down 1% and 1.24%, respectively, and on track for their worst weeks since September 2024.

Via Benzinga

Why Moderna Stock Has Surged 20% This Week Despite Mixed News ↗

March 07, 2025

Recent news has been mixed with a patent win and loss in Germany and the U.S. But Moderna stock has risen markedly this week.

Via Investor's Business Daily

Topics Intellectual Property

BioNTech Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

March 07, 2025

Via Benzinga

Peering Into BioNTech's Recent Short Interest ↗

January 28, 2025

Via Benzinga

Why BioNTech (BNTX) Shares Are Volatile Today ↗

January 13, 2025

Shares of BioNTech fell 4% on Monday. Vaccine stocks are volatile after Moderna's updated revenue guidance for 2025, which fell below analyst expectations.

Via Benzinga

Critical Insights From BioNTech Analyst Ratings: What You Need To Know ↗

December 11, 2024

Via Benzinga

FDA Places Clinical Hold On BioNTech's Early-Phase Trial For RNA-Based Malaria Vaccine ↗

March 05, 2025

BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with regulators on next steps.

Via Benzinga

BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025

February 24, 2025

From BioNTech SE

Via GlobeNewswire

Electronic Arts Posts Upbeat Earnings, Joins Mattel, Johnson Controls, Mueller Water Products And Other Big Stocks Moving Higher On Wednesday ↗

February 05, 2025

Via Benzinga

RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box. ↗

February 04, 2025

RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines in favor of his nomination.

Via Investor's Business Daily

Pfizer Edges Higher As Covid Sales Decline, But Still Beat Expectations ↗

February 04, 2025

Pfizer stock rose moderately early Tuesday on the back of its quarterly beat.

Via Investor's Business Daily

BioNTech Completes Acquisition of Biotheus

February 03, 2025

From BioNTech SE

Via GlobeNewswire

Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots ↗

January 24, 2025

Moderna won an agreement for its Covid vaccines in Europe on Friday, but Moderna stock reversed its early gains.

Via Investor's Business Daily

3 Dirt-Cheap Stocks to Buy in a Market That's Priced for Perfection ↗

January 22, 2025

Via The Motley Fool

Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio? ↗

January 19, 2025

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,...

Via Benzinga

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell? ↗

January 14, 2025

Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025.

Via Investor's Business Daily

BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference

January 14, 2025

From BioNTech SE

Via GlobeNewswire

BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst ↗

January 10, 2025

Truist rates BioNTech a Buy, citing its shift to oncology with BNT327 leading the way. Key data updates and growth catalysts are expected by 2025.

Via Benzinga

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. ↗

January 09, 2025

Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.

Via Investor's Business Daily

Topics Artificial Intelligence Government

Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside ↗

January 07, 2025

Jefferies upgrades Instil Bio to "Buy" with a $52 target, anticipating significant growth for PD-(L)1xVEGF class and SYN2510's potential in cancer treatments.

Via Benzinga

Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike ↗

January 07, 2025

Moderna, BioNTech and Novavax stocks popped after the CDC noted a recent increase in positive Covid tests.

Via Investor's Business Daily

5 Predictions for the Stock Market in 2025 -- and Which Stocks Will Soar the Most If They're Right ↗

January 04, 2025

Via The Motley Fool

Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy ↗

December 18, 2024

Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS.

Via Investor's Business Daily

3 No-Brainer Biotech Stocks to Buy With $200 Right Now ↗

December 18, 2024

Via The Motley Fool

2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid ↗

December 11, 2024

Via The Motley Fool

2 No-Brainer Stocks to Buy Before the End of 2024 ↗

December 09, 2024

Via The Motley Fool

Why Is BioNTech Stock Trading Higher On Friday? ↗

December 06, 2024

BNT324/DB-1311 trial data show significant antitumor activity in various cancers, with high response rates in small cell lung and prostate cancer patients.

Via Benzinga

5 Top Stocks to Buy in December ↗

December 04, 2024

Take a closer look at these bargain-bin value stocks, quality dividend stocks, and one scorching-hot growth stock.

Via The Motley Fool

This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

November 19, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

71 72 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.